ASHLEY SCHMIDT: Open Payments
NPI 1699440222 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,174 in 51 payments from 16 companies in 2025. Trend: 2023 $513 · 2024 $730 · 2025 $1,174
Food & beverage: $1,090Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $361 |
| ABBVIE INC. | 8 | $147 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $102 |
| PFIZER INC. | 5 | $101 |
| Ipsen Biopharmaceuticals, Inc | 3 | $87 |
| Aimmune Therapeutics, Inc. | 3 | $66 |
| VIVUS LLC | 3 | $51 |
| Madrigal Pharmaceuticals | 2 | $50 |
| Ardelyx, Inc. | 3 | $49 |
| Intercept Pharmaceuticals, Inc. | 2 | $39 |
Products named: TREMFYA, IQIRVO, ZENPEP, LINZESS, ENTYVIO, PANCREAZE, XELJANZ, VELSIPITY.
Industry payments across NC — which companies pay providers there.
